Shares of Novo Integrated Sciences Inc. NVOS, +60.45% rallied 83% in volatile morning trading Wednesday, but have pulled back sharply from earlier highs, on the primary care services and products company’s second day as a Nasdaq-listed company. The stock, currently around its intraday lows, had traded up as much as 275.4% at its intraday high of $14.98. It has already been halted for volatility six times since the open. The company did not immediately respond to a request for comment or information. As of Tuesday, the stock was uplisted to the Nasdaq Capital Market from trading over the counter. Separately, the company disclosed late Tuesday that director Robert Oliva acquired a total of $41,210 worth of shares this week through open market or private purchases; Oliva bought 9,355 shares at $4.31 on Monday and 200 shares at $4.45 on Tuesday. Oliva now owns 194,717 Novo shares, or just 0.1% of the shares outstanding.
View Article Origin Here
